Taking On Challenges And Growing? – DENTSPLY Sirona Inc (XRAY)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of DENTSPLY Sirona Inc is $5.02B. A total of 2.95 million shares were traded on the day, compared to an average of 2.76M shares.

In the most recent transaction, LUCIER GREGORY T bought 3,577 shares of XRAY for 27.95 per share on May 31 ’24. After the transaction, the Director now owns 58,374 company shares. In a previous transaction on Nov 22 ’23, LUCIER GREGORY T bought 10,000 shares at 31.44 per share. XRAY shares that Director owns now total 43,121.

Among the insiders who bought shares, Coleman Glenn acquired of 10,000 shares on Nov 20 ’23 at a per-share price of $29.70. This resulted in the Executive VP & CFO holding 73,566 shares of XRAY after the transaction. In another insider transaction, Campion Simon D bought 10,000 shares at $29.70 per share on Nov 20 ’23. Company shares held by the President, CEO & Member of BOD now total 243,930.


The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. XRAY’s most recent ex-dividend date was 6/28/2024 when it declared a $0.16 quarterly dividend that was paid in cash on 7/12/2024. Previously, the company paid the dividend on 4/12/2024 with an ex-dividend date of 3/27/2024. The XRAY stock dividend was $0.16 per share in cash.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, XRAY has a high of $41.65 and a low of $24.27.

As of this writing, XRAY has an earnings estimate of $0.5 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $0.54 per share and a lower estimate of $0.45. The company reported an EPS of $0.51 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. XRAY’s latest balance sheet shows that the firm has $339.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.29B in debt and $1.26B in liabilities at the time. Its Book Value Per Share was $15.69, while its Total Shareholder’s Equity was $5.00B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRAY is Buy with a score of 4.00.

Most Popular

Related Posts